Career history of Ralph Peter Cardinal
Former positions of Ralph Peter Cardinal
| Companies | Position | Start | End |
|---|---|---|---|
| UROLOGIX, INC. | Chief Tech/Sci/R&D Officer | 2010-10-13 | 2012-02-09 |
Leptos Biomedical, Inc.
 Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Corporate Officer/Principal | 2010-01-31 | 2010-01-31 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 2006-12-31 | 2006-12-31 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Chief Tech/Sci/R&D Officer | 2006-03-31 | 2006-03-31 |
Training of Ralph Peter Cardinal
| University of Wyoming | Undergraduate Degree |
| National Technological University | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| UROLOGIX, INC. | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Health Technology |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
- Stock Market
- Insiders
- Ralph Peter Cardinal
- Experience
